The increasing incidence of multiple-drug-resistant mycobacterial infections indicates that the development of new methods for treatment of mycobacterial diseases should be a high priority. meso-Diaminopimelic acid (DAP), a key component of a highly immunogenic subunit of the mycobacterial peptidoglycan layer, has been implicated as a potential virulence factor. The mycobacterial DAP biosynthetic pathway could serve as a target for design of new antimycobacterial agents as well as the construction of in vivo selection systems. We have isolated the asd, dapA, dapB, dapD, and dapE genes involved in the DAP biosynthetic pathway ofMycobacterium bovis BCG. These genes were isolated by complementation of Escherichia coil mutations with an expression library of BCG DNA. Our analysis of these genes suggests that BCG may use more than one pathway for biosynthesis of DAP. The nucleotide sequence of the BCG dapB gene was determined. The activity of the product of this gene in Escherichia coli provided evidence that the gene may encode a novel bifunctional dihydrodipicolinate reductase and DAP dehydrogenase.Mycobacterial diseases, such as tuberculosis and leprosy, currently cause the highest number of deaths of any infectious disease throughout the world (3). In particular, the recent rise in the incidence of antibiotic-resistant tuberculosis in the United States has increased the awareness of the importance of controlling the spread of mycobacterial diseases. Our laboratory has chosen to use three major approaches for the development of methods to combat mycobacterial diseases: (i) to develop a further understanding of the mechanisms that allow mycobacteria to cause disease, (ii) to find an effective and practical method of vaccination against mycobacteria, and (iii) to investigate potential methods of treatment of mycobacterial diseases. To this end, we have begun to examine important mycobacterial biosynthetic pathways that may be used in the development of marker systems for use in the study of pathogenesis, in the construction of recombinant vaccine strains, and as potential targets for new antibiotics.Diaminopimelic acid (DAP) is an essential component of the peptidoglycan layer of mycobacterial cell walls, which are known to have unusual immunogenic potential. Interestingly, N-glucolylmuramyl-L-alanyl-D-isoglutaminyl -meso -diaminopimelate is an immunological adjuvant and enhances cellular and humoral responses in guinea pigs when administered with an antigen (9). Study of the pathways involved in biosynthesis of the cell wall may lead to a better understanding of the causes of these immunological effects. The peptidoglycan layer of mycobacteria has unusual inter-DAP linkages as well as the standard DAP-D-alanine linkages (22). This fact results in an unusually high DAP content in the mycobacterial cell wall. The importance of the DAP molecule has been further suggested by work with Bordetella pertussis, for which DAP has been shown to play a key role in the structure of a cytotoxin (13). Disruption of biosynthesis o...